Showing results (661-670 of 2,709) with videos related to

Sort By:
Pageof 271
Fundamental & Clinical Pharmacology|January 1, 1989
Interaction between moclobemide and oral tyramine in depressed patientsC D Burgess, G W Mellsop
Fundamental & Clinical Pharmacology|May 1, 2016
Effect of glatiramer acetate on short-term memory impairment induced by lipopolysaccharide in male miceFatemeh Mohammadi, Reza Rahimian, Nahid Fakhraei, et al.
Fundamental & Clinical Pharmacology|March 8, 2016
Impact of fraction unbound, CYP3A, and CYP2D6 in vivo activities, and other potential covariates to the clearance of tramadol enantiomers in patients with neuropathic painNatália V de Moraes, Gabriela R Lauretti, Eduardo B Coelho, et al.
Fundamental & Clinical Pharmacology|March 8, 2016
Cilostazol exerts antiplatelet and anti-inflammatory effects through AMPK activation and NF-kB inhibition on hypercholesterolemic ratsNadia Alice Vieira da Motta, Fernanda Carla Ferreira de Brito
Fundamental & Clinical Pharmacology|November 12, 2015
Compliance of psychotropic drug prescription with clinical practice guidelines in older inpatientsFanny Etchepare, Elodie Pambrun, Bernard Bégaud, et al.
Fundamental & Clinical Pharmacology|July 17, 2013
Pharmacokinetics and absolute bioavailability of phenobarbital in neonates and young infants, a population pharmacokinetic modelling approachAmélie Marsot, Véronique Brevaut-Malaty, Renaud Vialet, et al.
Fundamental & Clinical Pharmacology|January 1, 1990
Pharmacokinetics of perindopril and its metabolites in healthy volunteersJ P Devissaguet, N Ammoury, M Devissaguet, et al.
Fundamental & Clinical Pharmacology|January 1, 1990
A comparative study of cyproheptadine and DL carnitine on psychomotor performance and memory in healthy volunteersF Hakkou, C Jaouen, L Iraki
Fundamental & Clinical Pharmacology|September 11, 2015
The pharmacokinetic-pharmacodynamic model of telmisartan and hydrochlorothiazide on blood pressure and plasma potassium after long-term administration in spontaneously hypertensive ratsDan Yu, Yuancheng Chen, Kun Hao
Fundamental & Clinical Pharmacology|January 13, 2025
Repurposing bosentan as an anticancer agent: EGFR/ERK/c-Jun modulation inhibits NSCLC tumor growthMarwa M Khalaf, Marina N Malak, Tariq G Alsahli, et al.
Pageof 271